AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 223 filers reported holding AXSOME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,196,615 | +1.3% | 60,046 | +4.2% | 0.00% | +50.0% |
| Q2 2023 | $4,141,938 | +3.5% | 57,639 | -11.1% | 0.00% | 0.0% |
| Q1 2023 | $4,000,503 | +8.0% | 64,859 | +35.0% | 0.00% | 0.0% |
| Q4 2022 | $3,705,633 | +82.8% | 48,044 | +5.8% | 0.00% | +100.0% |
| Q3 2022 | $2,027,000 | +14.3% | 45,421 | -1.9% | 0.00% | 0.0% |
| Q2 2022 | $1,774,000 | -11.7% | 46,313 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $2,009,000 | +6.4% | 48,529 | -3.0% | 0.00% | 0.0% |
| Q4 2021 | $1,889,000 | -28.6% | 50,005 | -37.7% | 0.00% | 0.0% |
| Q3 2021 | $2,645,000 | -15.1% | 80,227 | +73.7% | 0.00% | -50.0% |
| Q2 2021 | $3,117,000 | -3.5% | 46,198 | -19.0% | 0.00% | 0.0% |
| Q1 2021 | $3,230,000 | -25.5% | 57,050 | +7.3% | 0.00% | -33.3% |
| Q4 2020 | $4,334,000 | +30.2% | 53,185 | +13.9% | 0.00% | +50.0% |
| Q3 2020 | $3,328,000 | -12.0% | 46,707 | +1.7% | 0.00% | -33.3% |
| Q2 2020 | $3,780,000 | +36.9% | 45,941 | -2.1% | 0.00% | +50.0% |
| Q1 2020 | $2,761,000 | -26.9% | 46,933 | +28.5% | 0.00% | 0.0% |
| Q4 2019 | $3,775,000 | +2450.7% | 36,532 | +392.1% | 0.00% | – |
| Q3 2019 | $148,000 | -96.8% | 7,424 | -95.8% | 0.00% | -100.0% |
| Q2 2019 | $4,559,000 | – | 177,112 | +52927.5% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 334 | -95.6% | 0.00% | – |
| Q4 2017 | $42,000 | – | 7,634 | +22352.9% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 34 | -99.8% | 0.00% | – |
| Q2 2017 | $95,000 | +331.8% | 17,431 | +197.3% | 0.00% | – |
| Q1 2017 | $22,000 | -53.2% | 5,863 | -17.5% | 0.00% | – |
| Q4 2016 | $47,000 | +235.7% | 7,108 | +288.6% | 0.00% | – |
| Q3 2016 | $14,000 | +16.7% | 1,829 | +5.2% | 0.00% | – |
| Q2 2016 | $12,000 | -62.5% | 1,738 | -53.7% | 0.00% | – |
| Q1 2016 | $32,000 | – | 3,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |